Lv4
770 积分 2024-01-12 加入
Organelle-Targeted BODIPY-Conjugated Platinum(IV) Anticancer Prodrugs for Overcoming Drug Resistance
29天前
已完结
Engineered ketoreductase-catalyzed stereoselective reduction of ethyl 2′-ketopantothenate and its analogues: chemoenzymatic synthesis of d-pantothenic acid
1个月前
已完结
1,4-Dithiane-2,5-diol: A Versatile Synthon for the Synthesis of Sulfur-containing Heterocycles
1个月前
已完结
Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
1个月前
已完结
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
2个月前
已完结
Fragment Addition-Based Design of Heteroaromatic-Biphenyl-DAPYs as Potent and Orally Available Non-nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Enhanced Safety
2个月前
已完结
Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy
2个月前
已完结
Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance
2个月前
已完结
Structure-Based Discovery of Novel Piperidine-Biphenyl-DAPY Derivatives as Non-nucleoside Reverse Transcriptase Inhibitors Featuring Improved Potency, Safety, and Selectivity: From Piperazine-Biphenyl-DAPYs to Piperidine-Biphenyl-DAPYs
2个月前
已完结
Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens
2个月前
已完结
皖公网安备34019202002308
